Is Aqueous Film-Forming Foam (AFFF) safe for babies and kids?
Context-dependent for kidsNot medical or professional safety advice, and not a substitute for a qualified clinician — consult one. Full disclaimer →
(Babies-specific data is limited; this page draws from human pregnant context.) Pregnancy alters the metabolism and distribution of Aqueous Film-Forming Foam (AFFF), potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.
What is aqueous film-forming foam (afff)?
The IUPAC name is sodium 2,2,3,3,4,4,5,5,6,6,6-undecafluorohexanoate.
Also known as: sodium 2,2,3,3,4,4,5,5,6,6,6-undecafluorohexanoate, Sodium perfluorohexanoate, Sodium undecafluorohexanoate, Undecafluorohexanoic acid, sodium salt.
- IUPAC name
- sodium 2,2,3,3,4,4,5,5,6,6,6-undecafluorohexanoate
- CAS number
- 2923-26-4
- Molecular formula
- C6F11NaO2
- Molecular weight
- 336.03 g/mol
- SMILES
- [Na+].[O-]C(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
- PubChem CID
- 23678863
Risk for babies
Context-dependentPregnancy alters the metabolism and distribution of Aqueous Film-Forming Foam (AFFF), potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.
No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.
Risk for pregnant and nursing people
Context-dependentPregnancy alters the metabolism and distribution of Aqueous Film-Forming Foam (AFFF), potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.
No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.
Regulatory consensus
2 regulatory and scientific bodies have classified Aqueous Film-Forming Foam (AFFF). The classifications differ — that's the data.
| Agency | Year | Classification | Notes |
|---|---|---|---|
| GHS | — | Skin hazard | |
| GHS | — | Inhalation hazard |
Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.
Where kids encounter aqueous film-forming foam (afff)
- Industrial Facilities — Manufacturing plants, Waste treatment sites
- Occupational Environments — Factories, Warehouses
Safer alternatives
Lower-risk approaches that achieve a similar outcome to Aqueous Film-Forming Foam (AFFF):
-
Safer process chemistry; Green chemistry alternatives; Exposure controls
Trade-offs: Requires R&D investment to redesign synthesis routes; may reduce yield or throughput initially; long-term benefits include reduced waste treatment costs, regulatory compliance, and worker safety; 12 Principles of Green Chemistry framework available.Relative cost: 1.2-2×
Frequently asked questions
What products contain aqueous film-forming foam (afff)?
Aqueous Film-Forming Foam (AFFF) appears in: Manufacturing plants (Industrial facilities); Waste treatment sites (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).
See Aqueous Film-Forming Foam (AFFF) in the baby app
Look up products containing aqueous film-forming foam (afff), compare to alternatives, and explore the full data record.
Open in baby View raw API dataSources (7)
- PubChem Compound CID 23678863 — database
- EPA CompTox Chemicals Dashboard — DTXSID3052856 — epa
- ATSDR Toxicological Profile — CAS 2923-26-4 — reference
- ATSDR Toxicological Profile for Perfluoroalkyls (PFAS class — PFOA, PFOS, PFNA, PFHxS, PFBS) (2021) — regulatory
- EPA PFAS Strategic Roadmap — Aqueous Film-Forming Foam (AFFF) regulatory framework (2021) — regulatory
- US DoD PFAS Task Force — AFFF Phase-Out Implementation Guidance (NDAA 2020 §322 + 2023 §347) (2023) — regulatory
- Trowbridge et al. — Serum PFAS levels in firefighters cohort (PFNA + PFHxS elevation post-foam exposure) (2020) — study
Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for medical, pediatric, legal, or regulatory advice. Why we built ALETHEIA →